BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 27659130)

  • 1. Systematic review of renal carcinoma prognostic factors.
    Lorente D; Trilla E; Meseguer A; Planas J; Placer J; Celma A; Salvador C; Regis L; Morote J
    Actas Urol Esp; 2017 May; 41(4):215-225. PubMed ID: 27659130
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A postoperative prognostic nomogram predicting recurrence for patients with conventional clear cell renal cell carcinoma.
    Sorbellini M; Kattan MW; Snyder ME; Reuter V; Motzer R; Goetzl M; McKiernan J; Russo P
    J Urol; 2005 Jan; 173(1):48-51. PubMed ID: 15592023
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preoperative prognostic nomogram (probability table) for renal cell carcinoma based on TNM classification.
    Kanao K; Mizuno R; Kikuchi E; Miyajima A; Nakagawa K; Ohigashi T; Nakashima J; Oya M
    J Urol; 2009 Feb; 181(2):480-5; discussion 485. PubMed ID: 19100568
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic factors and predictive models in renal cell carcinoma: a contemporary review.
    Sun M; Shariat SF; Cheng C; Ficarra V; Murai M; Oudard S; Pantuck AJ; Zigeuner R; Karakiewicz PI
    Eur Urol; 2011 Oct; 60(4):644-61. PubMed ID: 21741163
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A review of integrated staging systems for renal cell carcinoma.
    Meskawi M; Sun M; Trinh QD; Bianchi M; Hansen J; Tian Z; Rink M; Ismail S; Shariat SF; Montorsi F; Perrotte P; Karakiewicz PI
    Eur Urol; 2012 Aug; 62(2):303-14. PubMed ID: 22575911
    [TBL] [Abstract][Full Text] [Related]  

  • 6. p53-expression in patients with renal cell carcinoma correlates with a higher probability of disease progression and increased cancer-specific mortality after surgery but does not enhance the predictive accuracy of robust outcome models.
    Morshaeuser L; May M; Burger M; Otto W; Hutterer GC; Pichler M; Klatte T; Wild P; Buser L; Brookman-May S
    Urol Oncol; 2018 Mar; 36(3):94.e15-94.e21. PubMed ID: 29221641
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Validation and extension of the Memorial Sloan-Kettering prognostic factors model for survival in patients with previously untreated metastatic renal cell carcinoma.
    Mekhail TM; Abou-Jawde RM; Boumerhi G; Malhi S; Wood L; Elson P; Bukowski R
    J Clin Oncol; 2005 Feb; 23(4):832-41. PubMed ID: 15681528
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Can the Kattan nomogram still accurately predict prognosis in renal cell carcinoma using the revised 2010 tumor-nodes-metastasis reclassification?
    Veeratterapillay R; Rakhra S; El-Sherif A; Johnson M; Soomro N; Heer R
    Int J Urol; 2012 Aug; 19(8):773-6. PubMed ID: 22487261
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development and external validation of a nomogram predicting disease specific survival after nephrectomy for papillary renal cell carcinoma.
    Klatte T; Remzi M; Zigeuner RE; Mannweiler S; Said JW; Kabbinavar FF; Haitel A; Waldert M; de Martino M; Marberger M; Belldegrun AS; Pantuck AJ
    J Urol; 2010 Jul; 184(1):53-8. PubMed ID: 20478577
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic factors and molecular markers for renal cell carcinoma.
    Bui MH; Zisman A; Pantuck AJ; Han KR; Wieder J; Belldegrun AS
    Expert Rev Anticancer Ther; 2001 Dec; 1(4):565-75. PubMed ID: 12113089
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nomograms incorporating serum C-reactive protein effectively predict mortality before and after surgical treatment of renal cell carcinoma.
    Hsiao W; Herrel LA; Yu C; Kattan MW; Canter DJ; Carthon BC; Ogan K; Master VA
    Int J Urol; 2015 Mar; 22(3):264-70. PubMed ID: 25428139
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic factors in patients receiving third line targeted therapy for metastatic renal cell carcinoma.
    Iacovelli R; Farcomeni A; Sternberg CN; Cartenì G; Milella M; Santoni M; Cerbone L; Di Lorenzo G; Verzoni E; Ortega C; Sabbatini R; Ricotta R; Messina C; Lorusso V; Atzori F; De Vincenzo F; Sacco C; Boccardo F; Valduga F; Massari F; Baldazzi V; Cinieri S; Mosca A; Maria Ruggeri E; Berruti A; Procopio G
    J Urol; 2015 Jun; 193(6):1905-10. PubMed ID: 25433306
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High expression of Mucin13 associates with grimmer postoperative prognosis of patients with non-metastatic clear-cell renal cell carcinoma.
    Xu Z; Liu Y; Yang Y; Wang J; Zhang G; Liu Z; Fu H; Wang Z; Liu H; Xu J
    Oncotarget; 2017 Jan; 8(5):7548-7558. PubMed ID: 27911274
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Renal cell carcinoma with vascular invasion: Mortality and prognostic factors.
    Rodríguez-Cabello MA; Laso-García I; Donis-Canet F; Gómez-Dos-Santos V; Varona-Crespo C; Burgos-Revilla FJ
    Actas Urol Esp; 2017 Mar; 41(2):132-138. PubMed ID: 27461850
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Validation of the current prognostic models for nonmetastatic renal cell carcinoma after nephrectomy in Chinese population: a 15-year single center experience.
    Liu Z; Lv J; Ding K; Fu Q; Cao Q; Wang F
    Int J Urol; 2009 Mar; 16(3):268-73. PubMed ID: 19087209
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low CCL-21 expression associates with unfavorable postoperative prognosis of patients with metastatic renal cell carcinoma.
    Xiong Y; Liu L; Wang J; Xi W; Xia Y; Bai Q; Qu Y; Long Q; Xu J; Guo J
    Oncotarget; 2017 Apr; 8(15):25650-25659. PubMed ID: 27783999
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Renal carcinoma: clinical, diagnostic and prognostic aspects.
    Reis M; Faria V
    Arch Esp Urol; 1994 Sep; 47(7):739-43. PubMed ID: 7802483
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of STAT3 protein as a prognostic factor in the clear cell renal carcinoma. Systematic review.
    Lorente D; Trilla E; Meseguer A; Arevalo J; Nemours S; Planas J; Placer J; Celma A; Salvador C; Regis L; Schwartzmann I; Morote J
    Actas Urol Esp (Engl Ed); 2019 Apr; 43(3):118-123. PubMed ID: 30466966
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Contemporary external validation of the Leibovich model for prediction of progression after radical surgery for clear cell renal cell carcinoma.
    Beisland C; Gudbrandsdottir G; Reisæter LA; Bostad L; Wentzel-Larsen T; Hjelle KM
    Scand J Urol; 2015 Jun; 49(3):205-10. PubMed ID: 25423093
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Prognostic factors in patients with metastatic renal cell carcinoma].
    Inoue R; Takahashi A; Takasugi S; Masumori N; Tsukamoto T; Hasegawa T
    Hinyokika Kiyo; 2010 Feb; 56(2):75-9. PubMed ID: 20185990
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.